Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionPflug Koory, LLC
Latest Disclosed Ownership1,857 shares
Latest Disclosed Value $ 258,810
Pflug Koory, LLC reports 5.35% decrease in ownership of GILD / Gilead Sciences, Inc.

On April 21, 2026 - Pflug Koory, LLC filed a 13F-HR form disclosing ownership of 1,857 shares of Gilead Sciences, Inc. (CH:GILD) valued at $258,810 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 20, 2026 disclosing 1,962 shares of Gilead Sciences, Inc.. This represents a change in shares of -5.35% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-21 2026-03-31 13F GILEAD SCIENCES COM 375558103 1,857 -105 -5.35 259 7.50 0.1186
2026-01-20 2025-12-31 13F GILEAD SCIENCES COM 375558103 1,962 0 0.00 241 10.60 0.1124
2025-10-21 2025-09-30 13F GILEAD SCIENCES COM 375558103 1,962 0 0.00 218 0.00 0.1033
2025-07-21 2025-06-30 13F GILEAD SCIENCES COM 375558103 1,962 0 0.00 218 -0.91 0.1104
2025-04-17 2025-03-31 13F GILEAD SCIENCES COM 375558103 1,962 -181 -8.45 220 11.17 0.1224
2025-01-21 2024-12-31 13F GILEAD SCIENCES COM 375558103 2,143 150 7.53 198 17.96 0.1002
2025-01-15 2024-09-30 13F GILEAD SCIENCES COM 375558103 1,993 -27 -1.34 167 13.61 0.0821
2024-04-11 2024-03-31 13F GILEAD SCIENCES COM 375558103 2,020 -5 -0.25 148 -10.37 0.0728
2024-01-11 2023-12-31 13F GILEAD SCIENCES COM 375558103 2,025 0 0.00 164 8.61 0.0869
2023-10-30 2023-09-30 13F GILEAD SCIENCES COM 375558103 2,025 0 0.00 152 -3.21 0.0877
2023-07-21 2023-06-30 13F GILEAD SCIENCES COM 375558103 2,025 0 0.00 156 -7.14 0.0795
2023-04-20 2023-03-31 13F GILEAD SCIENCES COM 375558103 2,025 -100 -4.71 168 0.0913
2023-01-18 2022-12-31 13F GILEAD SCIENCES COM 375558103 2,125 -95 -4.28 0 -100.00 0.1012
2022-10-11 2022-09-30 13F GILEAD SCIENCES COM 375558103 2,220 0 0.00 137 0.00 0.0834
2022-08-01 2022-06-30 13F GILEAD SCIENCES COM 375558103 2,220 -100 -4.31 137 -0.72 0.0791
2022-04-14 2022-03-31 13F GILEAD SCIENCES COM 375558103 2,320 -375 -13.91 138 -29.59 0.0695
2022-01-20 2021-12-31 13F GILEAD SCIENCES COM 375558103 2,695 0 0.00 196 4.26 0.0989
2021-10-19 2021-09-30 13F GILEAD SCIENCES COM 375558103 2,695 -500 -15.65 188 -14.55 0.1028
2021-07-14 2021-06-30 13F GILEAD SCIENCES COM 375558103 3,195 500 18.55 220 26.44 0.1152
2021-07-13 2021-03-31 13F GILEAD SCIENCES COM 375558103 2,695 -638 -19.14 174 -10.31 0.0962
2021-01-14 2020-12-31 13F GILEAD SCIENCES COM 375558103 3,333 -490 -12.82 194 -19.83 0.1148
2020-10-20 2020-09-30 13F GILEAD SCIENCES COM 375558103 3,823 250 7.00 242 -12.00 0.1635
2020-07-30 2020-06-30 13F GILEAD SCIENCES COM 375558103 3,573 0 0.00 275 3.00 0.2038
2020-04-24 2020-03-31 13F GILEAD SCIENCES COM 375558103 3,573 0 0.00 267 15.09 0.2373
2020-01-14 2019-12-31 13F GILEAD SCIENCES COM 375558103 3,573 25 0.70 232 3.11 0.1640
2019-10-15 2019-09-30 13F GILEAD SCIENCES COM 375558103 3,548 65 1.87 225 -4.26 0.1708
2019-08-02 2019-06-30 13F GILEAD SCIENCES COM 375558103 3,483 -260 -6.95 235 -3.29 0.1800
2019-04-11 2019-03-31 13F GILEAD SCIENCES COM 375558103 3,743 -125 -3.23 243 0.41 0.1901
2019-01-24 2018-12-31 13F GILEAD SCIENCES COM 375558103 3,868 -1,250 -24.42 242 -38.73 0.2066
2018-11-06 2018-09-30 13F GILEAD SCIENCES COM 375558103 5,118 -280 -5.19 395 3.40 0.3195
2018-08-13 2018-06-30 13F GILEAD SCIENCES COM 375558103 5,398 0 0.00 382 -6.14 0.3017
2018-08-13 2018-03-31 13F GILEAD SCIENCES COM 375558103 5,398 -100 -1.82 407 3.30 0.3357
2018-08-13 2017-12-31 13F GILEAD SCIENCES COM 375558103 5,498 0 0.00 394 -11.46 0.3116
2018-08-13 2017-09-30 13F GILEAD SCIENCES COM 375558103 5,498 150 2.80 445 17.41 0.3638
2018-08-13 2017-06-30 13F GILEAD SCIENCES COM 375558103 5,348 415 8.41 379 13.13 0.3202
2018-08-13 2017-03-31 13F GILEAD SCIENCES COM 375558103 4,933 875 21.56 335 15.12 0.2929
2018-08-13 2016-12-31 13F GILEAD SCIENCES COM 375558103 4,058 4,058 291 0.2506
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.